-
More Alike than Different: Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder across Neuroimaging Modalities
Authors:
Nils R. Winter,
Ramona Leenings,
Jan Ernsting,
Kelvin Sarink,
Lukas Fisch,
Daniel Emden,
Julian Blanke,
Janik Goltermann,
Nils Opel,
Carlotta Barkhau,
Susanne Meinert,
Katharina Dohm,
Jonathan Repple,
Marco Mauritz,
Marius Gruber,
Elisabeth J. Leehr,
Dominik Grotegerd,
Ronny Redlich,
Andreas Jansen,
Igor Nenadic,
Markus Nöthen,
Andreas Forstner,
Marcella Rietschel,
Joachim Groß,
Jochen Bauer
, et al. (6 additional authors not shown)
Abstract:
Introduction: Identifying neurobiological differences between patients suffering from Major Depressive Disorder (MDD) and healthy individuals has been a mainstay of clinical neuroscience for decades. However, recent meta- and mega-analyses have raised concerns regarding the replicability and clinical relevance of brain alterations in depression. Methods: Here, we systematically investigate healthy…
▽ More
Introduction: Identifying neurobiological differences between patients suffering from Major Depressive Disorder (MDD) and healthy individuals has been a mainstay of clinical neuroscience for decades. However, recent meta- and mega-analyses have raised concerns regarding the replicability and clinical relevance of brain alterations in depression. Methods: Here, we systematically investigate healthy controls and MDD patients across a comprehensive range of modalities including structural magnetic resonance imaging (MRI), diffusion tensor imaging, functional task-based and resting-state MRI under near-ideal conditions. To this end, we quantify the upper bounds of univariate effect sizes, predictive utility, and distributional dissimilarity in a fully harmonized cohort of N=1,809 participants. We compare the results to an MDD polygenic risk score (PRS) and environmental variables. Results: The upper bound of the effect sizes range from partial eta squared = .004 to .017, distributions overlap between 89% and 95%, with classification accuracies ranging between 54% and 55% across neuroimaging modalities. This pattern remains virtually unchanged when considering only acutely or chronically depressed patients. Differences are comparable to those found for PRS, but substantially smaller than for environmental variables. Discussion: We provide a large-scale, multimodal analysis of univariate biological differences between MDD patients and controls and show that even under near-ideal conditions and for maximum biological differences, deviations are extremely small and similarity dominates. We sketch an agenda for a new focus of future research in biological psychiatry facilitating quantitative, theory-driven research, an emphasis on computational psychiatry and multivariate machine learning approaches, as well as the utilization of ecologically valid phenotyping.
△ Less
Submitted 20 December, 2021;
originally announced December 2021.
-
A Network Control Theory Approach to Longitudinal Symptom Dynamics in Major Depressive Disorder
Authors:
Tim Hahn,
Hamidreza Jamalabadi,
Daniel Emden,
Janik Goltermann,
Jan Ernsting,
Nils R. Winter,
Lukas Fisch,
Ramona Leenings,
Kelvin Sarink,
Vincent Holstein,
Marius Gruber,
Dominik Grotegerd,
Susanne Meinert,
Katharina Dohm,
Elisabeth J. Leehr,
Maike Richter,
Lisa Sindermann,
Verena Enneking,
Hannah Lemke,
Stephanie Witt,
Marcella Rietschel,
Katharina Brosch,
Julia-Katharina Pfarr,
Tina Meller,
Kai Gustav Ringwald
, et al. (9 additional authors not shown)
Abstract:
Background: The evolution of symptoms over time is at the heart of understanding and treating mental disorders. However, a principled, quantitative framework explaining symptom dynamics remains elusive. Here, we propose a Network Control Theory of Psychopathology allowing us to formally derive a theoretical control energy which we hypothesize quantifies resistance to future symptom improvement in…
▽ More
Background: The evolution of symptoms over time is at the heart of understanding and treating mental disorders. However, a principled, quantitative framework explaining symptom dynamics remains elusive. Here, we propose a Network Control Theory of Psychopathology allowing us to formally derive a theoretical control energy which we hypothesize quantifies resistance to future symptom improvement in Major Depressive Disorder (MDD). We test this hypothesis and investigate the relation to genetic and environmental risk as well as resilience.
Methods: We modelled longitudinal symptom-network dynamics derived from N=2,059 Beck Depression Inventory measurements acquired over a median of 134 days in a sample of N=109 patients suffering from MDD. We quantified the theoretical energy required for each patient and time-point to reach a symptom-free state given individual symptom-network topology (E 0 ) and 1) tested if E 0 predicts future symptom improvement and 2) whether this relationship is moderated by Polygenic Risk Scores (PRS) of mental disorders, childhood maltreatment experience, and self-reported resilience.
Outcomes: We show that E 0 indeed predicts symptom reduction at the next measurement and reveal that this coupling between E 0 and future symptom change increases with higher genetic risk and childhood maltreatment while it decreases with resilience.
Interpretation: Our study provides a mechanistic framework capable of predicting future symptom improvement based on individual symptom-network topology and clarifies the role of genetic and environmental risk as well as resilience. Our control-theoretic framework makes testable, quantitative predictions for individual therapeutic response and provides a starting-point for the theory-driven design of personalized interventions.
Funding: German Research Foundation and Interdisciplinary Centre for Clinical Research, Münster
△ Less
Submitted 21 July, 2021;
originally announced July 2021.
-
Genetic, Individual, and Familial Risk Correlates of Brain Network Controllability in Major Depressive Disorder
Authors:
Tim Hahn,
Nils R. Winter,
Jan Ernsting,
Marius Gruber,
Marco J. Mauritz,
Lukas Fisch,
Ramona Leenings,
Kelvin Sarink,
Julian Blanke,
Vincent Holstein,
Daniel Emden,
Marie Beisemann,
Nils Opel,
Dominik Grotegerd,
Susanne Meinert,
Walter Heindel,
Stephanie Witt,
Marcella Rietschel,
Markus M. Nöthen,
Andreas J. Forstner,
Tilo Kircher,
Igor Nenadic,
Andreas Jansen,
Bertram Müller-Myhsok,
Till F. M. Andlauer
, et al. (5 additional authors not shown)
Abstract:
Background: A therapeutic intervention in psychiatry can be viewed as an attempt to influence the brain's large-scale, dynamic network state transitions underlying cognition and behavior. Building on connectome-based graph analysis and control theory, Network Control Theory is emerging as a powerful tool to quantify network controllability - i.e., the influence of one brain region over others rega…
▽ More
Background: A therapeutic intervention in psychiatry can be viewed as an attempt to influence the brain's large-scale, dynamic network state transitions underlying cognition and behavior. Building on connectome-based graph analysis and control theory, Network Control Theory is emerging as a powerful tool to quantify network controllability - i.e., the influence of one brain region over others regarding dynamic network state transitions. If and how network controllability is related to mental health remains elusive.
Methods: From Diffusion Tensor Imaging data, we inferred structural connectivity and inferred calculated network controllability parameters to investigate their association with genetic and familial risk in patients diagnosed with major depressive disorder (MDD, n=692) and healthy controls (n=820).
Results: First, we establish that controllability measures differ between healthy controls and MDD patients while not varying with current symptom severity or remission status. Second, we show that controllability in MDD patients is associated with polygenic scores for MDD and psychiatric cross-disorder risk. Finally, we provide evidence that controllability varies with familial risk of MDD and bipolar disorder as well as with body mass index.
Conclusions: We show that network controllability is related to genetic, individual, and familial risk in MDD patients. We discuss how these insights into individual variation of network controllability may inform mechanistic models of treatment response prediction and personalized intervention-design in mental health.
△ Less
Submitted 21 July, 2021;
originally announced July 2021.
